ESC 365 - The COMPASS trial: a new paradigm in lower extremity artery disease?

ESC Premium Access

The COMPASS trial: a new paradigm in lower extremity artery disease?

Session: Essentials in PAD: New evidence since the PAD guidelines - Will they change our practice?

Topic: Treatment

Speaker: Professor O. Berwanger (London, GB)

Event: ESC Congress 2018

Congress Presentation

Add to my library

About the speaker

Professor Otavio Berwanger

Imperial College London, London (United Kingdom of Great Britain & Northern Ireland)

8 presentations

1 follower

3 more presentations in this session

Antidiabetic agents in lower extremity artery disease: save the patient? Save the limb?

Speaker: Professor M. Vrsalovic (Zagreb, HR)

Lipid lowering therapy in peripheral vascular disease. Which targets? Which drugs?

Speaker: Doctor I. Desormais (Limoges, FR)

Revascularisation in peripheral artery disease

Speaker: Professor M. Venermo (Helsinki, FI)

Access the full session

Essentials in PAD: New evidence since the PAD guidelines - Will they change our practice?

Speakers: Professor O. Berwanger, Professor M. Vrsalovic, Doctor I. Desormais, Professor M. Venermo

About the event

ESC Congress 2018

25 August - 29 August 2018

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources